Physician profile
Chad David Lavender
NPI 1932360955
$311,635.43
in general payments reported to CMS, 2019-2025
17 companies · $78K in 2025
The $78K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $20K · 2021: $38K · 2022: $44K · 2023: $53K · 2024: $53K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $98K · Consulting Fee: $65K · Travel and Lodging: $16K · Food and Beverage: $3,163 · Royalty Or License: $2,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $97,907.43 |
| Consulting Fee | $64,814.10 |
| Travel and Lodging | $16,291.35 |
| Food and Beverage | $3,162.71 |
| Royalty Or License | $2,215.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $306,907.35 | 2019-2025 | Arthrex |
| Mid-Atlantic Surgical Systems, LLC | $2,708.26 | 2019-2025 | |
| Abbott Laboratories | $966.06 | 2019-2025 | Eterna, Proclaim |
| Medwest Associates | $487.30 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $86.43 | 2019-2024 | Euflexxa |
| Smoky Mountain Surgical LLC | $79.72 | 2023 | |
| Pacira Therapeutics, INC. | $78.35 | 2020-2021 | |
| Spr Therapeutics, INC | $57.29 | 2020 | |
| Encore Medical, Lp | $49.59 | 2019 | |
| Team 1, LLC | $48.05 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $39.11 | 2022 | |
| Reel Surgical, INC. | $31.46 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $22.89 | 2025 | |
| Cosa Medical, LLC | $21.32 | 2024 | |
| Bioventus LLC | $18.97 | 2023 | Durolane |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mvp Orthopedics INC | $18.32 | 2023 | |
| Pinnacle, INC | $14.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Lavender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.